← Leaderboards
Michael Mannstadt
Massachusetts General Hospital
$4,555,232
Attributed
$4,555,232
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $415.8K · FY2008–23$500K$375K$250K$125K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$4,555,232 · 3
By mechanism
P01$1,946,478 · 1
R01$1,810,364 · 1
K08$798,390 · 1
Top collaborators
No co-investigators on record.
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Marc Nathan Wein$4,989,017
- Henry M Kronenberg$26,229,120
- Benjamin Z Leder$7,400,681
- Marie Demay$19,218,520
- John T Potts$1,716,912
Others in their field
Top investigators on “Biology”
- David Heimbrook · Leidos Biomedical Research, Inc.$731,505,112
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Lawrence Corey · Fred Hutchinson Cancer Center$543,202,300
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$480,487,534
- Tracy L Nolen · Research Triangle Institute$474,487,152
Research focus
BiologyCellsHomeostasisTranscription FactorProteinsCalciumBone HealthFutureFamilyFamily MemberRegulationProductionChromatin ImmunoprecipitationIn VitroBaseIn VivoGene TargetingHormonesHyperparathyroidismMissionEndocrine System DiseasesEmbryonic DevelopmentChronic Kidney FailureDominant-Negative Mutation
Grant awards (15)
The role of salt inducible kinases in renal PTH action$410,924
P01 · FY2023 · DK · contact PI
The role of salt inducible kinases in renal PTH action$410,924
P01 · FY2022 · DK · contact PI
The role of salt inducible kinases in renal PTH action$410,924
P01 · FY2021 · DK · contact PI
The role of salt inducible kinases in renal PTH action$415,788
P01 · FY2020 · DK · contact PI
The role of salt inducible kinases in renal PTH action$297,918
P01 · FY2019 · DK · contact PI
Mode of Action of GCM2, the Essential Parathyroid Transcription Factor$366,424
R01 · FY2018 · DK · contact PI
Mode of Action of GCM2, the Essential Parathyroid Transcription Factor$366,424
R01 · FY2017 · DK · contact PI
Mode of Action of GCM2, the Essential Parathyroid Transcription Factor$353,992
R01 · FY2016 · DK · contact PI
Mode of Action of GCM2, the Essential Parathyroid Transcription Factor$353,992
R01 · FY2015 · DK · contact PI
Mode of Action of GCM2, the Essential Parathyroid Transcription Factor$369,532
R01 · FY2014 · DK · contact PI
Dominant-negative GCMB mutations cause hypoparathyroidism$160,164
K08 · FY2012 · DK · contact PI
Dominant-negative GCMB mutations cause hypoparathyroidism$160,164
K08 · FY2011 · DK · contact PI
Dominant-negative GCMB mutations cause hypoparathyroidism$159,921
K08 · FY2010 · DK · contact PI
Dominant-negative GCMB mutations cause hypoparathyroidism$159,192
K08 · FY2009 · DK · contact PI
Dominant-negative GCMB mutations cause hypoparathyroidism$158,949
K08 · FY2008 · DK · contact PI